Laroprovstat clinical trials

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

This study is looking at a new combination medicine (laroprovstat/rosuvastatin) for people with high cholesterol who haven't taken cholesterol-lowering medicines before. It wants to see if this new combination is safe and effective at lowering 'bad' cholesterol (LDL-C) compared to its individual ingredients or a dummy pill.